Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix
- PMID: 23168774
- PMCID: PMC4054813
- DOI: 10.1097/aog.0b013e31827001d5
Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix
Abstract
In March 2012, the College of American Pathologists and American Society for Colposcopy and Cervical Pathology, in collaboration with 35 stakeholder organizations, convened a consensus conference called the Lower Anogenital Squamous Terminology (LAST) Project. The recommendations of this project include using a uniform, two-tiered terminology to describe the histology of human papillomavirus-associated squamous disease across all anogenital tract tissues: vulva, vagina, cervix, penis, perianus, and anus. The recommended terminology is "low-grade" or "high-grade squamous intraepithelial lesion (SIL)." This terminology is familiar to clinicians, because it parallels the terminology of the Bethesda System cytologic reports. Biopsy results using SIL terminology may be further qualified using "intraepithelial neoplasia" (IN) terminology in parentheses. Laboratory p16 tissue immunostaining is recommended to better classify histopathology lesions that morphologically would earlier have been diagnosed as IN 2. p16 is also recommended for differentiating between high-grade squamous intraepithelial lesions and benign mimics. The LAST Project recommendations potentially affect the application of current guidelines for managing cervical squamous intraepithelial lesions. The authors offer interim guidance for managing cervical lesions diagnosed using this new terminology with special attention paid to managing young women with cervical high-grade squamous intraepithelial lesions on biopsy. Clinicians should be aware of the LAST Project recommendations, which include important changes from prior terminology.
Conflict of interest statement
The other authors did not report any potential conflicts of interest.
Similar articles
-
The terminology of pre-invasive cervical lesions in the UK cervical screening programme.Cytopathology. 2015 Dec;26(6):346-50. doi: 10.1111/cyt.12307. Cytopathology. 2015. PMID: 26767601 Review.
-
Role of the Biomarker p16 in Downgrading -IN 2 Diagnoses and Predicting Higher-grade Lesions.Am J Surg Pathol. 2015 Dec;39(12):1708-18. doi: 10.1097/PAS.0000000000000494. Am J Surg Pathol. 2015. PMID: 26371784
-
Two-grade Bethesda system of reporting in cervical screening: colposcopist's view.Cytopathology. 2015 Dec;26(6):351-3. doi: 10.1111/cyt.12305. Cytopathology. 2015. PMID: 26767602 No abstract available.
-
Interobserver reproducibility of cervical histology interpretation with and without p16 immunohistochemistry.Am J Clin Pathol. 2024 Aug 1;162(2):202-209. doi: 10.1093/ajcp/aqae029. Am J Clin Pathol. 2024. PMID: 38527169
-
HPV-related squamous neoplasia of the lower anogenital tract: an update and review of recent guidelines.Adv Anat Pathol. 2014 Sep;21(5):341-58. doi: 10.1097/PAP.0000000000000035. Adv Anat Pathol. 2014. PMID: 25105936 Review.
Cited by
-
Risk factors related to recurrence after surgical excision procedure for cervical dysplasia.Hippokratia. 2023 Oct-Dec;27(4):132-140. Hippokratia. 2023. PMID: 39372323 Free PMC article.
-
Potential mechanisms of ZiGongDing in treating HPV-induced cervical intraepithelial neoplasia: a network pharmacology and experimental verification study.Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep 26. doi: 10.1007/s00210-024-03445-5. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 39325153
-
Optimal Screening and Detection Strategies for Cervical Lesions: A Retrospective Study.J Cancer. 2024 May 13;15(11):3612-3624. doi: 10.7150/jca.96128. eCollection 2024. J Cancer. 2024. PMID: 38817879 Free PMC article.
-
Aerobic vaginitis is associated with carbonic anhydrase IX in cervical intraepithelial neoplasia.Sci Rep. 2024 Apr 16;14(1):8789. doi: 10.1038/s41598-024-57427-x. Sci Rep. 2024. PMID: 38627429 Free PMC article.
-
Predictable changes in the accuracy of human papillomavirus tests after vaccination: review with implications for performance monitoring in cervical screening.Br J Cancer. 2024 May;130(11):1733-1743. doi: 10.1038/s41416-024-02681-z. Epub 2024 Apr 13. Br J Cancer. 2024. PMID: 38615108 Free PMC article. Review.
References
-
- Darragh TM, Colgan T, Cox JT, Heller DS, Henry MR, Luff RD, et al. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis. 2012;16:205–42. - PubMed
-
- Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12–9. - PubMed
-
- Parkin DM, Bray F. The burden of HPV-related cancers. Vaccine. 2006;24(suppl 3):11–25. - PubMed
-
- Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, Garland SM, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol. 2012;13:487–500. - PubMed
-
- Scurry J, Wilkinson EF. Review of terminology of precursors of vulvar squamous cell carcinoma. J Low Genit Tract Dis. 2006;10:161–9. - PubMed
